Security	Date	Code	Shares	Price	A/D	D/I	Nature of ownership
Common Stock^F1,F5	Dec 10, 2015	S$0	25,591	$0.00	D	I	See Footnotes
Common Stock^F2,F5	Dec 10, 2015	S$0	25,590	$0.00	D	I	See Footnotes
Common Stock^F1,F5	Dec 11, 2015	S$0	676,535	$0.00	D	I	See Footnotes
Common Stock^F2,F5	Dec 11, 2015	S$0	676,536	$0.00	D	I	See Footnotes
Common Stock^F3,F5	Dec 11, 2015	S$0	770,155	$0.00	D	I	See Footnotes
Common Stock^F4,F5	Dec 11, 2015	S$0	359,847	$0.00	D	I	See Footnotes
Common Stock^F1,F5	Dec 14, 2015	S$0	100,000	$0.00	D	I	See Footnotes
Common Stock^F2,F5	Dec 14, 2015	S$0	100,000	$0.00	D	I	See Footnotes
Common Stock^F3,F6	Dec 14, 2015	S$0	100,000	$0.00	D	I	See Footnotes
Common Stock^F6,F5	Dec 14, 2015	X	2,600,000	$0.00	A	I	See Footnotes

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrants^F5,F6	$0.47	Dec 14, 2015	X	2,600,000	D	May 7, 2013	May 7, 2018	Common Stock	2,600,000	0	I

Explanation of responses

F1Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"), of which Pillar Invest Corporation ("Pillar GP") is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. As of the date hereof, Pillar I owns directly 2,167,712 shares of common stock of the Issuer.
F2Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"), of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. As of the date hereof, Pillar II owns directly 5,979,959 shares of common stock of the Issuer.
F3Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"), of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. As of the date hereof, Pillar III owns directly 3,949,426 shares of common stock of the Issuer.
F4Shares sold by Pillar Pharmaceuticals IV, L.P. ("Pillar IV"), of which Pillar GP is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar IV and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar IV. As of the date hereof, Pillar IV owns directly 200,000 shares of common stock of the Issuer.
F5Youssef El Zein is a director and controlling stockholder of Pillar GP and serves as the representative of a Pillar I, Pillar II, Pillar III, Pillar IV and Pillar GP on the Issuer's board of directors. Mr. El Zein disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I, Pillar II, Pillar III and Pillar IV and this report shall not be deemed an admission that he is the beneficial owners of any such securities, except to the extent of his pecuniary interest therein, if any, by virtue of his ownership interest in Pillar GP. As of the date hereof, Mr. El Zein owns directly 496,920 shares of common stock of the Issuer.
F6Warrants beneficially owned and exercised for shares of common stock by Pillar III. Pillar GP disclaims Section 16 beneficial ownership of the Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the beneficial owner of any such securities, except to the extent of its pecuniary interest therein.